Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | -1.85 | N/A | N/A | N/A |
2024-08-01 | 2024-06 | -3.47 | -3.33 | 0.14 | 4.03% |
2024-05-02 | 2024-03 | -3.59 | N/A | N/A | N/A |
2024-05-02 | 2024-03 | -3.59 | -3.07 | 0.52 | 14.48% |
2024-02-22 | 2023-12 | -0.78 | N/A | N/A | N/A |
2024-02-22 | 2023-12 | -0.78 | 0.55 | 1.33 | 170.51% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-09-12 | Argus Research | Upgrade | Buy | Buy |
2023-08-03 | TD Cowen | Downgrade | Outperform | Market Perform |
2023-08-03 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-03 | B of A Securities | Upgrade | Neutral | Neutral |
2023-08-03 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-08-02 | Deutsche Bank | Downgrade | Buy | Hold |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-07-30 | AFEYAN NOUBAR BOGHOS | Director | 6.86M | Sale |
2022-12-27 | ANDRES JUAN | Chief Technology Officer | 12.80K | Sale |
2024-02-15 | BANCEL STEPHANE J | Chief Executive Officer | 21.08M | Sale |
2024-05-02 | BERENSON STEPHEN A. | Director | 22.20K | Conversion of Exercise of derivative security |
2023-12-05 | GARAY ARPA | Officer | 3.69K | Sale |
2024-09-02 | HOGE STEPHEN | President | 1.60M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Baillie Gifford and Company | 45.71M | 5.55B | 12.01% |
2023-06-29 | Vanguard Group Inc | 27.46M | 3.34B | 7.22% |
2023-06-29 | Blackrock Inc. | 24.16M | 2.94B | 6.35% |
2023-06-29 | State Street Corporation | 14.23M | 1.73B | 3.74% |
2023-06-29 | Flagship Pioneering Inc. | 12.89M | 1.57B | 3.39% |
2023-06-29 | Coatue Management LLC | 6.55M | 795.35M | 1.72% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.11M | 1.23B | 2.66% |
2023-05-30 | Vanguard International Growth Fund | 9.42M | 1.20B | 2.47% |
2023-06-29 | Vanguard 500 Index Fund | 7.81M | 948.38M | 2.05% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 6.46M | 730.48M | 1.70% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.45M | 523.90M | 1.17% |
2023-05-30 | Fidelity 500 Index Fund | 3.70M | 472.16M | 0.97% |
Split | Date |
---|---|
1 : 10 | 2017-08-03 |
-
-
-
Investors in $MRNA know that this is not just a vaccine stock. The cancer cures, rare disease cures, and so many more cures in the pipelines. The CDC never explained this, but these vaccines were never met to stop the spread. They were only made to stop the rapid hospitalization. I don’t know how any of you bears haven’t noticed that, so put the video games down and do your own research. The world is extremely bullish on mRNA technology.
-
$MRNA
Germany reporting 96 % of Omicron cases are in the people who fell for the propaganda jab !
Please wake up people, the jabs are destroying your immune system- just the opposite of what government told u ! -
Desperate weirdos spreading misinformation on here. Pure scum of the earth.
-
Still plenty of dumbfucks out there -
For all the conspiracy weirdo dumbfucks -
-
Too many people on here talking like the omicron numbers are overblown. Oh really??? Is that way Judge just mentioned he can’t get his car serviced because too many people at the dealership are sick? My cousin couldn’t get his car inspection because everywhere he called said same thing. Everyone is home sick they said. Same thing with my favorite pizza joint. Both locations closed due to all employees getting Covid. It’s everywhere now. This is insane. $MRNA
-
No one cares about common nomenclature here. Everyone only cares about the amount of money they’re making and the amount of orders that are on the daily for millions of doses. This is the stock market if you need a reminder. It’s an awful thing we all accept. $MRNA
-
FTFT surges and about to sky rocket!!
-
-
-
-
-
-
$MRNA Insiders are not selling like crazy and they’re probably exercising options to buy more cheap shares. The entire C-suite still owns the majority of their shares. Sometimes they have to sell something to pay taxes. Don’t let these bears influence anything. Oh wait, they’re not. Lol. I smell fear from the bears.
-
Bears promoting lies all day on here thinking somehow they’re going to influence the stock price. Are you scared? Are you scared of the squeeze? Did you wait until now to short? Bulls are here with data. Actual facts. Millions of vaccine shots ordered daily, whether we like it or not. And, it’s not just a vaccine company. They’re curing cancer, under the radar illnesses, with new drugs in the pipeline. Billions of dollars in cash on hand. BULLISH. $MRNA
-
$MRNA
Triple jabbed filling hospitals
30 year old men dropping dead of heart attacks after jabs .
When will the people wake up -
-
NTx Services Launches to Supercharge Next Generation mRNA Research
businesswire.com • -
Moderna (NASDAQ:MRNA) Shares Up 7%
news.google.com • -
Moderna (NASDAQ:MRNA) PT Lowered to $48.00
news.google.com • -
What's Going On With Moderna Shares Tuesday?
news.google.com • -
Where are the Opportunities in (MRNA)
news.google.com • -
Moderna (MRNA) Rises Higher Than Market: Key Facts
news.google.com • -
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein
news.google.com • -
Moderna: Cutting Costs At Just The Worst Time (NASDAQ:MRNA)
news.google.com • -
Class Action Lawsuit Against Moderna, Inc. (NASDAQ:MRNA)
news.google.com • -
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
news.google.com • -
Moderna Gets Analyst Downgrade After $1.1B R&D Spending Cut
news.google.com • -
‘Time to Move to the Sidelines,’ Says Jefferies About Moderna Stock
news.google.com • -
MRNA Stock Falls 12% on Lowered Sales Outlook, R&D Budget Cuts
news.google.com • -
Biotech Stocks Are Tumbling — But The Top 5 Are Standouts
news.google.com • -
Moderna's Move Shows Lack Of Confidence, Shrinks Pipeline (NASDAQ:MRNA)
news.google.com • -
Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around.
news.google.com • -
Moderna: Oddo BHF reduces its target after CMD
news.google.com • -
Moderna (NASDAQ:MRNA) Stock Falls 12% as R&D Budget Is Cut by $1B
news.google.com • -
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
news.google.com • -
Moderna Stock Plummets on Cost-Cutting Measures
news.google.com • -
Biggest stock movers today: WBD, MPW, MRNA, SIG, and more
news.google.com • -
Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs
news.google.com •